Chevron's $53B Hess Deal Faces Uncertainty Amid Exxon And CNOOC Arbitration Claims
Hess Says Arbitration Merits Hearing About Applicability Of Stabroek ROFR To Merger Scheduled For May 2025; Hess And Chevron Had Expected, Requested That This Hearing Be Held Earlier - Filing
Market Whales and Their Recent Bets on BAC Options
A Closer Look at Walmart's Options Market Dynamics
Check Out What Whales Are Doing With UNH
Check Out What Whales Are Doing With TMO
Procter & Gamble Analyst Ratings
Market Whales and Their Recent Bets on JPM Options
Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook
Favorite High-yield Dividend Stocks - BMO
J&J Wins Another FDA Label Expansion for Multiple Myeloma Therapy
Small Caps Have Nearly Caught up to the S&P 500: Morning Brief
Nasdaq Tumbles Amid Decline In Tech Stocks: Greed Index Moves To 'Fear' Zone
Consumer giants collectively performed poorly!
From Nestle to Procter & Gamble, and then to Starbucks, the entire consumer industry is showing signs of weakness, and the performance of consumer giants in the Chinese market is generally declining. As disposable income is constrained, consumers are increasingly focused on reducing consumption or turning to lower-priced commodities.
Another round of pre-announcement before the release! Will Japan raise interest rates and shrink its balance sheet at the same time? Technology stocks plummeted in response to the news overnight, and the Japanese yen rose.
NHK reports that the Bank of Japan is discussing raising interest rates to 0.25%, and combined with previous analyses, the central bank may propose specific measures to reduce the balance sheet at this meeting. Will this 'double whammy' affect global markets today?
Market Sells Off on Earnings Near Misses, FOMC Incoming | Wall Street Today
How Is The Market Feeling About Bank of America?
GSK Shingles Vaccine Cuts Dementia Risk
What's Going On With Exxon Mobil Shares Tuesday?
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations